[go: up one dir, main page]

GT201200017A - Preparacion de (r) y (s) - (3,4-difluoro-2-(2-fluoro-4-yodo-fenilamino-6-metoxifenil)-1-(2,3-dihidroxipropil) ciclopropan-1-sulfonamida y derivados protegidos de los mismos: - Google Patents

Preparacion de (r) y (s) - (3,4-difluoro-2-(2-fluoro-4-yodo-fenilamino-6-metoxifenil)-1-(2,3-dihidroxipropil) ciclopropan-1-sulfonamida y derivados protegidos de los mismos:

Info

Publication number
GT201200017A
GT201200017A GT201200017A GT201200017A GT201200017A GT 201200017 A GT201200017 A GT 201200017A GT 201200017 A GT201200017 A GT 201200017A GT 201200017 A GT201200017 A GT 201200017A GT 201200017 A GT201200017 A GT 201200017A
Authority
GT
Guatemala
Prior art keywords
dihydroxipropil
sulfonamide
difluoro
fluoro
ciclopropan
Prior art date
Application number
GT201200017A
Other languages
English (en)
Inventor
Maderna Andreas
Vernier Jean-Michel
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201200017(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of GT201200017A publication Critical patent/GT201200017A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCIÓN SE RELACIONA CON LA PREPARACIÓN DE (R)- N-(3,4-DIFLUORO-2-(2-FLUORO-4-YODOFENILAMINO)-6-METOXIFENIL)-1-(2,3-DIHIDROXIPROPIL) CICLOPROPRAN-1-SULFONAMIDA Y (S)-N-(3,4-DIFLUORO-2-(2-FLUORO-4-YODOFENILAMINO)-6METOXIFENIL)-1-(D,3-DIHIDROXIPROPIL) CICLOPROPAN-1- SULFONAMIDA.
GT201200017A 2009-07-24 2012-01-24 Preparacion de (r) y (s) - (3,4-difluoro-2-(2-fluoro-4-yodo-fenilamino-6-metoxifenil)-1-(2,3-dihidroxipropil) ciclopropan-1-sulfonamida y derivados protegidos de los mismos: GT201200017A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22850109P 2009-07-24 2009-07-24
US22850909P 2009-07-24 2009-07-24

Publications (1)

Publication Number Publication Date
GT201200017A true GT201200017A (es) 2013-12-19

Family

ID=42830488

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201200017A GT201200017A (es) 2009-07-24 2012-01-24 Preparacion de (r) y (s) - (3,4-difluoro-2-(2-fluoro-4-yodo-fenilamino-6-metoxifenil)-1-(2,3-dihidroxipropil) ciclopropan-1-sulfonamida y derivados protegidos de los mismos:

Country Status (31)

Country Link
US (3) US8513443B2 (es)
EP (1) EP2462111B1 (es)
JP (1) JP5776115B2 (es)
KR (1) KR101763437B1 (es)
CN (2) CN103848808B (es)
AR (1) AR079183A1 (es)
AU (1) AU2010275780B2 (es)
BR (1) BR112012001592A2 (es)
CA (2) CA2768788C (es)
CL (1) CL2012000192A1 (es)
CO (1) CO6491075A2 (es)
CR (1) CR20120044A (es)
CU (1) CU24113B1 (es)
DO (1) DOP2012000017A (es)
EA (1) EA023623B1 (es)
EC (1) ECSP12011621A (es)
GT (1) GT201200017A (es)
HN (1) HN2012000142A (es)
IL (1) IL217312A (es)
IN (1) IN2012DN00696A (es)
MA (1) MA33452B1 (es)
MX (2) MX2012001063A (es)
MY (1) MY160421A (es)
NZ (1) NZ597738A (es)
PE (1) PE20120573A1 (es)
PH (1) PH12014500158A1 (es)
SG (1) SG177535A1 (es)
TN (1) TN2012000027A1 (es)
TW (1) TWI524890B (es)
UY (1) UY32800A (es)
WO (1) WO2011009541A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備
MX362823B (es) * 2011-05-27 2019-02-18 Ardea Biosciences Inc Star Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino] -6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas.
WO2013094546A1 (ja) 2011-12-19 2013-06-27 住友化学株式会社 スルホン酸塩の製造方法
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495118B (zh) * 2005-07-21 2012-09-05 阿迪亚生命科学公司 Mek的n-(芳基氨基)磺酰胺抑制剂
US8101799B2 (en) 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
CA2649122C (en) * 2006-04-18 2015-06-30 Ardea Biosciences, Inc. Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
CA2924418A1 (en) * 2007-07-30 2009-02-05 Jean-Michel Vernier Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
CN102131771A (zh) * 2008-04-14 2011-07-20 阿迪生物科学公司 组合物及其制备和使用方法
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備

Also Published As

Publication number Publication date
US20130261320A1 (en) 2013-10-03
HN2012000142A (es) 2015-06-08
PH12014500158B1 (en) 2015-09-07
EP2462111A1 (en) 2012-06-13
CA2768788A1 (en) 2011-01-27
HK1171218A1 (en) 2013-03-22
PH12014500158A1 (en) 2015-09-07
NZ597738A (en) 2014-03-28
CU20120014A7 (es) 2012-06-21
US20150274651A1 (en) 2015-10-01
MY160421A (en) 2017-03-15
EA201200175A1 (ru) 2012-12-28
SG177535A1 (en) 2012-03-29
IN2012DN00696A (es) 2015-06-19
US8513443B2 (en) 2013-08-20
KR101763437B1 (ko) 2017-07-31
MX344965B (es) 2017-01-12
TN2012000027A1 (en) 2013-09-19
BR112012001592A2 (pt) 2016-03-08
CN102471246B (zh) 2015-08-26
WO2011009541A1 (en) 2011-01-27
PE20120573A1 (es) 2012-05-17
AU2010275780A1 (en) 2012-02-02
CA2768788C (en) 2018-01-09
EA023623B1 (ru) 2016-06-30
AR079183A1 (es) 2012-01-04
UY32800A (es) 2011-01-31
EP2462111B1 (en) 2016-03-30
MX2012001063A (es) 2012-03-26
CO6491075A2 (es) 2012-07-31
IL217312A0 (en) 2012-02-29
IL217312A (en) 2017-02-28
ECSP12011621A (es) 2012-02-29
CL2012000192A1 (es) 2012-10-05
CN102471246A (zh) 2012-05-23
US20120178946A1 (en) 2012-07-12
KR20120032536A (ko) 2012-04-05
TW201113017A (en) 2011-04-16
HK1198364A1 (zh) 2015-04-10
AU2010275780B2 (en) 2015-10-22
JP2013500242A (ja) 2013-01-07
DOP2012000017A (es) 2012-05-15
CN103848808B (zh) 2016-02-10
US8884058B2 (en) 2014-11-11
CR20120044A (es) 2012-03-12
US9296686B2 (en) 2016-03-29
MA33452B1 (fr) 2012-07-03
CU24113B1 (es) 2015-08-27
TWI524890B (zh) 2016-03-11
CN103848808A (zh) 2014-06-11
CA2990097A1 (en) 2011-01-27
JP5776115B2 (ja) 2015-09-09

Similar Documents

Publication Publication Date Title
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
ECSP10010722A (es) Compuestos orgánicos
EA201270254A1 (ru) Производные 5-фторпиримидинона
IN2012DN00692A (es)
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
MA32369B1 (fr) Composes de benzene sulfonamide thiazole et oxazole
UA107445C2 (uk) 5-фторпіримідинові похідні як фунгіциди
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
SV2010003472A (es) Compuestos de pirazol
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
CY1113102T1 (el) Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
AR074222A1 (es) Derivados lantibioticos carboxiamida con actividad antibacterial mejorada, procedimiento de obtencion sus composiciones farmaceuticas derivados carboxamida y empleo de los mismos
IN2012DN00695A (es)
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
MX372721B (es) Ánalogos halogenados de agentes antifi-broticos.
SV2009003429A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
GT200600117A (es) Nuevos compuestos farmaceuticos
GT201200017A (es) Preparacion de (r) y (s) - (3,4-difluoro-2-(2-fluoro-4-yodo-fenilamino-6-metoxifenil)-1-(2,3-dihidroxipropil) ciclopropan-1-sulfonamida y derivados protegidos de los mismos:
ES2530436T3 (es) Combinación
TN2012000381A1 (en) 2-aldoximino-5-fluoropyrimidine derivatives
CO6700896A2 (es) Procesos para la preparación de enaminas
HN2008000082A (es) Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamidas, su preparacion y aplicacion en terapeutica
UY30085A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion su aplicacion en terapeutica